NCT07087795CompletedPhase 1
A study to see the effect of NNC0194-0499 alone or in combination with semaglutide on blood sugar control in people living with type 1 diabetes.
Source: EU CTIS (euclinicaltrials.eu) · Last updated 27 Jul 2026
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 96 (actual)
- First submitted
- 4 Apr 2025
- Start date
- 24 Jun 2025
- Lead sponsor
- Novo Nordisk A/S
- Diseases
- Type 1 diabetes
- EU CT number
- 2024-519533-38-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 96
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| PROFIL Institut fuer Stoffwechselforschung GmbH Coordinator of this site? Confirm its status | Neuss | Germany | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.